Born from a company founded in New Zealand in 2005, Izon Science was renamed in 2008 when it became focused on its mission of becoming a truly global business at the interface of nanotechnology and biology. Led by former CEO and current founder director Hans van der Voorn from 2007 to March 2022, the company grew its team, expertise and product range in nanoparticle separation and analysis.  

Izon is a world leader in TRPS, a technology which enables nanoparticles to be analysed with an unmatched level of resolution. While TRPS was always part of the vision, Izon’s development of tools for nanoparticle isolation entered the scene later on. Since the first launch of the qEVoriginal in 2014, the range of Legacy columns has evolved to accommodate different sample loading volumes from 150 µL to 100 mL. qEV columns have since been used to analyse diverse sample types across a wide range of applications. The introduction of the Automatic Fraction Collector (AFC) in 2019 marked a major shift from labour-intensive manual collection to a rapid and reproducible method that can be scaled up for larger-scale biomarker studies.

Izon remains committed to continuous improvement and continues to refine and expand its offerings. In 2021, Izon released the first Gen 2 qEV columns, which outperform their Legacy predecessors. The release of the Gen 2 columns – and exciting projects in the works – reflect Izon’s commitment to providing a scalable way forward for EV applications, including EV-based diagnostics.